FHTX CIK: 1822462

Foghorn Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−117
FY23:
−108
FY24:
−103
FY25:
−86.4
(positive)
Change from FY21 to FY23
millions USD
FY21:
−95.0
FY22:
−114
FY23:
−104
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY24
millions USD
FY21:
−101
FY22:
−109
FY23:
−94.2
FY24:
−86.6
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−101
FY22:
−109
FY23:
−98.4
FY24:
−86.6
FY25:
−74.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data